PYXS
Pyxis Oncology Inc
NASDAQ: PYXS · HEALTHCARE · BIOTECHNOLOGY
$1.70
+2.41% today
Updated 2026-04-30
Market cap
$106.81M
P/E ratio
—
P/S ratio
7.71x
EPS (TTM)
$-1.28
Dividend yield
—
52W range
$1 – $6
Volume
0.4M
Pyxis Oncology Inc (PYXS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-159.50%
ROE
-91.40%
ROA
-41.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-2.67M | — | — | — |
| 2020 | $0.00 | $-12.83M | — | — | — |
| 2021 | $0.00 | $-75.97M | — | — | — |
| 2022 | $0.00 | $-117.95M | — | — | — |
| 2023 | $0.00 | $-73.79M | — | — | — |
| 2024 | $16.15M | $-77.33M | 97.06% | -554.07% | -478.95% |
| 2025 | $13.86M | $-79.62M | 82.77% | -609.18% | -574.55% |